You are here: Industry Insights > Rheumatoid Arthritis

News List

Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research americanpharmaceuticalreview
August 20, 2019
Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention ...
EMA Validates Marketing Application for Filgotinib for Rheumatoid Arthritis americanpharmaceuticalreview
August 19, 2019
Gilead Sciences and Galapagos announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults with rheumatoid arthritis (RA) has been validated and ...
New Vaccine in the Treatment of Rheumatoid Arthritis biospectrumasia
July 09, 2019
CEL-SCI Collaborators Presents Data for New Vaccine in the Treatment of Rheumatoid Arthritis at the International Conference on Immunity and Immunochemistry Meeting Second Rheumatoid Arthritis vaccine discovered which acts alone and can complement the exi
Statins Safe, Effective in Rheumatoid Arthritis Patients drugs
April 22, 2019
Statins Safe, Effective in Rheumatoid Arthritis Patients
Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan expressbpd
March 27, 2019
Biosimilar Etanercept is indicated to treat moderate to severe rheumatoid arthritis (RA) and juvenile idiopathic arthritis
FDA agrees to review AbbVie’s upadacitinib in rheumatoid arthritis pharmaceutical-technology
February 21, 2019
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted by AbbVie for its investigational medicine upadacitinib to treat adults with moderate to severe rheumatoid arthritis....
Phone-Based Intervention Aids Rheumatoid Arthritis Care drugs
December 17, 2018
A nurse-based phone education intervention can promote shared decision making in patients with newly diagnosed rheumatoid arthritis (RA), according to a study published online Dec. 5 in Musculoskeletal Care.....
FDA approves Sandoz’s biosimilar of Humira pharmaceutical
November 19, 2018
The US Food and Drug Administration (FDA) has approved Novartis subsidiary Sandoz’s biosimilar of AbbVie’s Humira, Hyrimoz, for seven indications: rheumatoid arthritis...
Johnson & Johnson drops OSE’s rheumatoid arthritis drug fiercebiotech
November 05, 2018
Johnson & Johnson has dumped OSE Immunotherapeutics’ autoimmune candidate FR104. J&J picked up the rights to the CD28 antagonist for...
Flu Vaccine Cuts Mortality in Rheumatoid Arthritis Patients drugs
August 01, 2018
Patients with rheumatoid arthritis (RA), particularly elderly patients, who receive the influenza vaccine have significantly lower morbidity and mortality, according to a study published in the June issue of the International Journal of Rheumatic Diseases

Previous page 1 2 3 4 5 6 Next page